C P Schneider
Overview
Explore the profile of C P Schneider including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
121
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wendt T, Gademann G, Pambor C, von Specht H, Martin T, Baltas D, et al.
Strahlenther Onkol
. 2016 May;
180 Suppl 1:5-87.
PMID: 27137922
No abstract available.
2.
Horsch D, Grabowski P, Schneider C, Petrovitch A, Kaemmerer D, Hommann M, et al.
Drugs Today (Barc)
. 2011 Nov;
47(10):773-86.
PMID: 22076492
Neuroendocrine tumors are heterogeneous in their clinical behavior and require therapies specially tailored according to staging and grading, origin and expression of peptide receptors. Somatostatin analogues act as antisecretory and...
3.
Tan E, Rolski J, Grodzki T, Schneider C, Gatzemeier U, Zatloukal P, et al.
Ann Oncol
. 2009 Mar;
20(7):1249-56.
PMID: 19276396
Background: The study compared the efficacy of a first-line treatment with day 1 i.v. vinorelbine (NVBiv) and day 8 oral vinorelbine (NVBo) versus docetaxel (DCT) in a cisplatin-based combination in...
4.
Walz C, Zedler S, Schneider C, Mayr S, Loehe F, Bruns C, et al.
Langenbecks Arch Surg
. 2007 Mar;
392(3):339-43.
PMID: 17377804
Introduction: Prolonged immunosuppression has been demonstrated after trauma-hemorrhage resulting in an increased susceptibility to sepsis. The contribution of antigen-presenting cells (APC) vs T cells to this diminished immune response, however,...
5.
Hartl W, Wolf H, Schneider C, Fertmann J, Kuchenhoff H, Jauch K
Dtsch Med Wochenschr
. 2006 Oct;
131(44):2456-60.
PMID: 17066354
Background: The association of multiple organ failure and acute prognosis is an established fact in intensive care medicine. However, it is unclear whether the number of failing organs is an...
6.
Schneider C, Wolf H, Kuchenhoff H, Jauch K, Hartl W
Chirurg
. 2006 Jun;
77(8):700-8.
PMID: 16786339
Background: For critically ill medical patients until the year 2000, increases in patient age and severity of disease but also acute prognosis have been described. Since then, further improvement appears...
7.
Klippstein A, Schneider C, Sayer H, Hoffken K
J Cancer Res Clin Oncol
. 2003 May;
129(5):316-9.
PMID: 12756557
Background: Bendamustine is an alkylator with anticipated antimetabolic activity. It has shown activity in malignant lymphoma, multiple myeloma, and breast cancer. Recognized side-effects are relatively mild with myelosuppression as the...
8.
Schwacha M, Schneider C, Bland K, Chaudry I
Am J Physiol Cell Physiol
. 2001 Sep;
281(4):C1180-7.
PMID: 11546654
The activation of a macrophage (Mphi)-dependent proinflammatory cascade following thermal injury plays an important role in the development of immunosuppression and increased susceptibility to subsequent sepsis in burn patients. In...
9.
Schneider C, Nickel E, SAMY T, Schwacha M, Cioffi W, Bland K, et al.
Shock
. 2000 Oct;
14(3):347-53.
PMID: 11028555
Studies have shown that immune responses are depressed in male mice, but not in proestrus females after trauma-hemorrhage (TH), resulting in increased mortality from subsequent sepsis in male mice compared...
10.
Kath R, Fiehler J, Schneider C, Hoffken K
J Cancer Res Clin Oncol
. 2000 Apr;
126(4):233-7.
PMID: 10782897
Whether gastric cancer in young adults differs from gastric cancer in older patients has been a controversial issue. It has long been suspected that young patients with gastric cancer have...